What is Agdia?
Established in 1981, Agdia Inc. serves as a critical pillar in the agricultural industry, specializing in the development and distribution of test kits for plant pathogens and transgenic traits. By providing validated, field-ready diagnostic solutions, the company enables producers, laboratories, and breeders to maintain crop health and regulatory compliance. Their comprehensive portfolio includes detection assays for viruses, bacteria, and fungi, alongside bespoke custom assay development services. This technical expertise positions Agdia as an essential partner for stakeholders navigating the complexities of modern plant pathology and genetic modification verification.
How much funding has Agdia raised?
Agdia has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Agdia
PPP
Public-Private Partnership
What's next for Agdia?
As Agdia transitions through this late-stage growth phase, the focus shifts toward scaling its diagnostic capabilities to meet the increasing demand for food security and sustainable agricultural practices. The recent capital infusion is expected to accelerate the development of next-generation testing platforms, potentially expanding their reach into emerging markets where rapid, on-site pathogen detection is becoming a regulatory and operational necessity. By leveraging its decades of research experience, the company is well-positioned to integrate advanced molecular diagnostic techniques into its existing product suite, ensuring that it remains at the forefront of the agricultural diagnostics market while maintaining its commitment to accuracy and rapid turnaround times for its global client base.
See full Agdia company page
